The Jordanian Pharmaceutical Manufacturing Co. PLC Stock Forecast for 2022 - 2025 - 2030
Updated on 05/25/2022
The Jordanian Pharmaceutical Manufacturing Co. PLC Fair Value Forecast for 2022 - 2025 - 2030
In the past two years, The Jordanian Pharmaceutical Manufacturing Co. PLC's Fair Value has grown by 100%, rising from 0.00 to 0.00. For the next year, analysts predict that Fair Value will reach 0.00 – an increase of 100%. Over the next nine years, experts believe that JPHM's Fair Value will grow at a rate of 100%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
The Jordanian Pharmaceutical Manufacturing Co. PLC Revenue Forecast for 2022 - 2025 - 2030
In the past one years, The Jordanian Pharmaceutical Manufacturing Co. PLC's Revenue has decreased significantly, from 22.21M to 9.98M – a 55.07% drop. For the next year, analysts predict that Revenue will reach 22.21M – an increase of 122.55%. Over the next eleven years, experts believe that JPHM's Revenue will grow at a rate of 5223.89%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
The Jordanian Pharmaceutical Manufacturing Co. PLC Free Cash Flow Forecast for 2022 - 2025 - 2030
The Jordanian Pharmaceutical Manufacturing Co. PLC's Free Cash Flow have decreased by 15.97% in the past one years, from -2380000.00 to just -2000000.00. In the next year, analysts believe that Free Cash Flow will reach a reasonable -2380000.00 – an increase of 19% For the next eleven years, the forecast is for Free Cash Flow to grow by 14.2%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
The Jordanian Pharmaceutical Manufacturing Co. PLC Net Income Forecast for 2022 - 2025 - 2030
In the past one years, The Jordanian Pharmaceutical Manufacturing Co. PLC's Net Income has seen a relatively significant increase, rising from -4100000.00 to -5860000.00. This represents a growth of 42.93%. For the following year, the 0 analysts predict that JPHM's Net Income will drop by 30.03%, reaching -4907644.14. In 2030, the professionals' prediction is that JPHM's Net Income will decrease by 16.25%, reaching -4907644.14.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
The Jordanian Pharmaceutical Manufacturing Co. PLC EBITDA Forecast for 2022 - 2025 - 2030
Over the past one years, The Jordanian Pharmaceutical Manufacturing Co. PLC's EBITDA has decreased from 1.37M to -5870000.00 – a 528.47% drop! In the coming year, analysts are expecting a significant increase in EBITDA, predicting it will reach -13110058.00 – an increase of 123.34%. Over the next eleven years, experts anticipate that EBITDA growth for The Jordanian Pharmaceutical Manufacturing Co. PLC will be 135.99%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
The Jordanian Pharmaceutical Manufacturing Co. PLC EBIT Forecast for 2022 - 2025 - 2030
In the past one years, The Jordanian Pharmaceutical Manufacturing Co. PLC has seen a decline in its EBIT, from 780.00k to just -6290000.00 – a staggering 906.41% decrease. In the next year, analysts predict that EBIT will reach an impressive -13359960.00 – an increase of 112.4%. For the next eleven years, the forecast is for EBIT to grow by 119.42%
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|
The Jordanian Pharmaceutical Manufacturing Co. PLC EPS Price Prediction Forecast for 2022 - 2025 - 2030
In the past two years, The Jordanian Pharmaceutical Manufacturing Co. PLC's EPS has grown by 525%, rising from -0.04 to -0.25. In the following year, 0 experts forecast that The Jordanian Pharmaceutical Manufacturing Co. PLC's EPS will decrease by 28%, to -0.19. In 2030, professionals predict that The Jordanian Pharmaceutical Manufacturing Co. PLC's EPS will decrease by 22.38%, to -0.19.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts |
|---|